Disc Medicine, Inc.

NASDAQ:IRON

Biotechnology

Healthcare
$76.11 -0.03%

-$0.02 today

Market cap
$2.92B
Beta
2.10
P/E (TTM)
-11.2
EPS (TTM)
-$6.28
52W Low $40.00High $99.50

Volume 0.65M

Average 0.47M

Returns on capital

Disc Medicine, Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-28.7%

avg 23.5%

ROIC

-30.6%

avg -4322.6%

ROA

-26.3%

avg -103.7%

Analysis

ROA is currently the strongest return metric at -26.3% versus its period average of -103.7%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

John D. Quisel

Chief Executive Officer, President & DirectorUSD 1.26M55150.12K0.39%

Jean Franchi

Chief Financial OfficerUSD 838.98K60——

William Jacob Savage

Chief Medical OfficerUSD 836.84K5263.45K0.17%

Pamela Stephenson

Chief Commercial OfficerUSD 832.1K5881.00K0.21%

Jonathan Yu

Chief Opearating OfficerUSD 811.56K45——

Donald William Nicholson

Executive ChairmanUSD 170K696.21K0.02%

Brian MacDonald

Founder & Chair of Scientific Advisory BoardUSD 88.54K65——

Rahul Rajan Kaushik

Chief Technical Officer————

Srikanth Venkatraman

Senior Vice President & Head of Chemistry————

Lisa Amaya Price

Chief Human Resources Officer————

Rahul Khara

Chief Legal Officer & Secretary—4449.80K0.13%

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Nov 10, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

0

$0.00

Sells

96

$48.75M

Net Transaction Value

−$48.75M

Net selling

Most Active

Bitterman Kevin

47 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Nov 10, 26

Savage William Jacob

Direct

Sell$1.4M
Oct 21, 26

Bitterman Kevin

Indirect

Sell$21.3K
Oct 21, 26

Bitterman Kevin

Indirect

Sell$1.1M
Oct 21, 26

Bitterman Kevin

Indirect

Sell$920.2K
Oct 20, 26

Bitterman Kevin

Indirect

Sell$229.4K
Oct 20, 26

Bitterman Kevin

Indirect

Sell$190.9K
Oct 20, 26

Bitterman Kevin

Indirect

Sell$4.4K
Oct 19, 26

Bitterman Kevin

Indirect

Sell$395.2K
Oct 19, 26

Bitterman Kevin

Indirect

Sell$9.2K
Oct 19, 26

Bitterman Kevin

Indirect

Sell$474.8K

1–10 of 96

Summary

Insiders reported 0 buys worth $0.00 and 96 sells worth $48.75M over the last 12 months. That adds up to net selling of $48.75M. Bitterman Kevin was the most active insider with 47 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A4 analysts
RevenueN/AN/AN/A
N/A5 analysts
Net IncomeN/AN/AN/A
N/A5 analysts
EBITN/AN/AN/A
N/A5 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Competitors

Who does Disc Medicine, Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about IRON's management, answered from reported figures.

Who manages IRON?

Disc Medicine, Inc. (IRON) lists 11 active executives. The top listed executive is Brian MacDonald, Founder & Chair of Scientific Advisory Board.

Are IRON insiders buying or selling?

Recent insider activity shows net selling of $105.57M.